Is prostate cancer incidence worldwide linked to artificial light at night exposures? Review of earlier findings and analysis of current trends

Archives of Environmental and Occupational Health

Volumn 72, Issue 2, 2017, Pages 111-122

  Rybnikova, Nataliya A ^a   Haim, Abraham ^a   Portnov, Boris A ^a  

^a UNIVERSITY OF HAIFA   (Israel)

Author keywords

Age standardized incidence rates; artificial light at night (ALAN); circadian disruption; melatonin suppression; regional differences; world countries

Indexed keywords

ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; HUMAN; LIGHT EXPOSURE; MALE; NIGHT; PRIORITY JOURNAL; PROSTATE CANCER; DEMOGRAPHY; ELECTRICITY; GLOBAL HEALTH; ILLUMINATION; INCIDENCE; PROSTATIC NEOPLASMS; REGISTER; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

GUANOSINE DIPHOSPHATE;

ELECTRICITY; GLOBAL HEALTH; GUANOSINE DIPHOSPHATE; HUMANS; INCIDENCE; LIGHTING; MALE; PROSTATIC NEOPLASMS; REGISTRIES; RESIDENCE CHARACTERISTICS; RISK FACTORS;

EID: 84976283554     PISSN: 19338244     EISSN: 21544700     Source Type: Journal    
DOI: 10.1080/19338244.2016.1169980     Document Type: Article

References (63)

1. World Cancer Research Fund International (WCRFI). Worldwide data. http://www.wcrf.org/int/cancer-facts-figures/worldwide-data. Published 2014. Accessed November18, 2014.
2. International Agency for Research on Cancer (GLOBOCAN). Estimated cancer incidence, mortality and prevalence worldwide in 2012. http://globocan.iarc.fr/Default.aspx. Accessed November18, 2014.
3. American Cancer Society (ACS). Do we know what causes prostate cancer? http://www.cancer.org/cancer/prostatecancer/detailedguide/prostate-cancer-what-causes. Published 2014. Accessed November20, 2014.
4. American Cancer Society (ACS). What are the risk factors for prostate cancer? http://www.cancer.org/cancer/prostatecancer/detailedguide/prostate-cancer-risk-factors. Published 2014. Accessed November19, 2014.
5. Prostate Cancer Foundation (PCF). Prostate cancer risk factors. http://www.pcf.org/site/c.leJRIROrEpH/b.5802027/k.D271/Prostate_Cancer_Risk_Factors.htm. Published 2014. Accessed November19, 2014.
6. Baade PD, Youlden DR, Coory MD, Gardiner RA, Chambers SK. Urban–rural differences in prostate cancer outcomes in Australia:what has changed? Med J. 2001;194:293–296.
7. Baldwin LM, Andrilla CH, Porter MP, Rosenblatt RA, Patel S, Doescher MP. Treatment of early-stage prostate cancer among rural and urban patients. Cancer. 2013;119:3067–3075.
8. Michaud DS, Augustsson K, Rimm EB, Stampfer MJ, Wilett WC, Giovannucci E. A prospective study on intake of animal products and risk of prostate cancer. Cancer Causes Control. 2001;12:557–567.
9. Charles LE, Loomis D, Shy CM, et al. Electromagnetic Fields, polychlorinated biphenyls, and prostate cancer mortality in electric utility workers. Am J Epidemiol. 2002;157:683–691.
10. Conlon M, Lightfoot N, Kreiger N. Rotating shift work and risk of prostate cancer. Epidemiology. 2007;18:182–183.
11. Kubo T, Ozasa K, Mikami K, et al. Prospective cohort study of the risk of prostate cancer among rotating-shift workers:Findings from the Japan collaborative cohort study. Am J Epidemiol. 2006;164:549–555.
12. Kloog I, Haim A, Stevens R, Portnov B. Global co-distribution of light at night (LAN) and cancers of prostate, colon, and lung in men. Chronobiol Int. 2009;26:108–125.
13. Haim A, Portnov BA. Light Pollution as a New Risk Factor for Human Breast and Prostate Cancers. Dordrecht, Netherlands:Springer; 2013.
14. Mahadevan R, Asafu-Adjaye J. Energy consumption, economic growth and prices:a reassessment using panel VECM for developed and developing countries. Energy Policy. 2006;35:2481–2490.
15. National Oceanic and Atmospheric Administration (NOAA). Global Radiance Calibrated Night-time Lights. http://ngdc.noaa.gov/eog/dmsp/download_radcal.html. Published 2014. Accessed November18, 2014.
16. International Agency for Research on Cancer (GLOBOCAN). Estimated cancer incidence, mortality and prevalence worldwide in 2012:data sources and methods. http://globocan.iarc.fr/Pages/DataSource_and_methods.aspx. Published 2012. Accessed November18, 2014.
17. Machii R, Saika K. Estimated disability-adjusted life year (DALY) in Asia in GLOBOCAN 2008. Jpn J Clin Oncol. 2013;43:846–847.
18. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden:Globocan 2000. Int J Cancer. 2001;94:153–156.
19. Rosen A, Jayram G, Drazer M, Eggener SE. Global trends in testicular cancer incidence and mortality. Eur Urol. 2011;60:374–379.
20. National Cancer Institute (NCI). Cancer statistics:A cancer incidence rate. http://surveillance.cancer.gov/statistics/types/incidence.html. Published 2014. Accessed August21, 2014.
21. Steinwachs DM, Hughes RG. Health services research:scope and significance. In:Hughes RG, ed. Patient Safety and Quality:An Evidence-Based Handbook for Nurses. Rockville, MD:Agency for Health Care Research and Quality; 2008:chap 8.
22. International Agency for Research on Cancer (GLOBOCAN). Glossary of terms http://globocan.iarc.fr/Pages/glossary.aspx. Published 2012. Accessed September4, 2014.
23. European Commission (EC). Health effects of artificial light. http://ec.europa.eu/health/scientific_committees/opinions_layman/artificial-light/en/index.htm. Published 2014. Accessed September14, 2014.
24. Elvidge C, Baugh K, Zhizhin M, Hsu F. Why VIIRS data are superior to DMSP for mapping night-time lights. Proceedings of the Asia-Pacific Advanced Network. 2013;35:62–69.
25. Etzioni R, Cha R, Feuer EJ, Davidov O. Asymptomatic incidence and duration of prostate cancer. Am J Epidemiol. 1998;148:775–785.
26. World Health Organization (WHO). World report on violence and health. http://www.who.int/violence_injury_prevention/violence/world_report/en/summary_en.pdf. Published 2002. Accessed October5, 2014.
27. Kloog I, Stevens R, Haim A, Portnov B. Nighttime light level co-distributes with breast cancer incidence worldwide. Cancer Causes Control. 2010;21:2059–2068.
28. The GeoNames geographical database (GeoNames). http://download.geonames.org/export/dump/. Published 2014. Accessed November18, 2014.
29. United Nations Environment Programme (UNEP). Overview of the Milliennium Ecosystem Assessment. http://www.unep.org/maweb/en/About.aspx. Published 2014. Accessed October13, 2014.
30. ArcGIS Resource Center (ArcGIS RC). Zonal statistics. http://resources.arcgis.com/en/help/main/10.2/index.html#//009z000000w7000000. Published 2014. Accessed October5, 2014.
31. World Cancer Research Fund International (WCRFI). Comparing more & less developed countries. http://www.wcrf.org/int/cancer-facts-figures/comparing-more-less-developed-countries. Published 2014. Accessed November19, 2014.
32. Han X, Naeher LP. A review of traffic-related air pollution exposure assessment studies in the developing world. Environ Int. 2006;32:106–120.
33. US Energy Information Administration (USEIA). Energy consumption and efficiency. http://www.eia.gov/consumption/data.cfm#rec. Published 2014. Accessed September14, 2014.
34. Morrison RW, DeJong KA. Measurement of population diversity. In:Collet P, Fonlupt C, Hao JK, Lutton E, Schoenauer M, eds. Artificial Evolution. Berlin, Germany:Springer; 2002:31–41.
35. Garland FC, Garland CF, Gorham ED, Young JF. Geographic variation in breast cancer mortality in the United States:a hypothesis involving exposure to solar radiation. Prev Med. 1990;19:614–622.
36. The World Bank (WB). GDP per capita. http://data.worldbank.org/indicator/ NY.GDP.PCAP.CD?page = 2. Published 2014. Accessed November18, 2014.
37. The World Bank (WB). Urban population. http://data.worldbank.org/indicator/SP.URB.TOTL.IN.ZS?page=2. Published 2014. Accessed November18, 2014.
38. The International Energy Statistics (IES). Total electricity net consumption. http://www.eia.gov/cfapps/ipdbproject/IEDIndex3.cfm?tid=2&pid=2&aid=2. Published 2014. Accessed November18, 2014.
39. Sakia RM. The Box-Cox transformation technique:a review. Statistician. 1992;41:169–178.
40. GeoDa Center for Geospatial Analysis and Computation (GeoDa). Spatial regression with GeoDa. http://www.s4.brown.edu/S4/Training/Modul2/GeoDa3FINAL.pdf. Published 2014. Accessed September14, 2014.
41. GeoDa Center for Geospatial Analysis and Computation (GeoDa). Glossary of key terms. https://geodacenter.asu.edu/node/390. Published 2014. Accessed May24, 2014.
42. Pacheco AI, Tyrrel TJ. Testing spatial patterns and growth spillover effects in clusters of cities. Geog J. 2002;4:275–285.
43. Roux AVD, Franklin TG, Alazraqui M, Spinell H. Intraurban variations in adult mortality in a large Latin American city. J Urban Health.2007; 84:319–333.
44. United Nations Department of Economic and Social Affairs (UN DESA). Challenges facing SIDS. http://sustainabledevelopment.un.org/index.php?menu=1520. Published 2014. Accessed November27, 2014.
45. Fotheringham AS, Rogerson PA. The SAGE Handbook of Spatial Analysis. London, UK:SAGE; 2009.
46. Zhang Q, Seto KC. Mapping urbanization dynamics at regional and global scales using multi-temporal DMSP/OLS nighttime light data. Remote Sens Environ. 2011;115:2320–2329.
47. Ma T, Zhou C, Pei T, Haynie S, Fan J. Quantitative estimation of urbanization dynamics using time series of DMSP/OLS nighttime light data:a comparative case study from China's cities. Remote Sens Environ. 2012;124:99–107.
48. Lewy AJ, Wehr TA, Goodwin FK, Newsome DA, Markey SP. Light suppresses melatonin secretion in humans. Science. 1980;210:1267–1269.
49. McIntyre IM, Norman TR, Burrows GD, Armstrong SM. Human melatonin suppression by light is intensity dependent. J Pineal Res. 1989;6:149–156.
50. Schernhammer E, Schulmeister K. Melatonin and cancer risk:does light at night compromise physiologic cancer protection by lowering serum melatonin levels? Br J Cancer. 2004;90:941–943.
51. Cajochen C, Munch M, Kobialka S, et al. High sensitivity of human melatonin, alertness, thermoregulation, and heart rate to short wavelength light. J Clin Endocrinol Metab. 2005;90:1311–1316.
52. Navara KJ, Nelson RJ. The dark side of light at night:physiological, epidemiological, and ecological consequences. J Pineal Res. 2007;43:215–224.
53. Wertheimer N, Leeper E. Magnetic field exposure related to cancer subtypes. Ann NY Acad Sci. 1987;502:43–54.
54. Haim A, Yukler A, Harel O, Schwimmer H, Fares F. Effects of chronobiology on prostate cancer cells growth in vivo. Sleep Science. 2010;3:32–35.
55. Haim A, Zubidat, AE. Artificial light at night:melatonin as a mediator between the environment and epigenome. Philos Trans R Soc Lond B Biol Sci. 2015;370:1667.
56. Anisimov VN, Egormin PA, Piskunova TS, et al. Metformin extends life span of HER-2/neu transgenic mice and in combination with melatonin inhibits growth of transplantable tumors in vivo. Cell Cycle. 2010;9:188–197.
57. Jemal A, Bray F, Center M, Ferlay J, Ward E, Forman D. Global cancer statistics. Cancer J Clin. 2011;61:69–90.
58. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents:defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24:2137–2150.
59. World Health Organization (WHO). Global incidence and prevalence of selected curable sexually transmitted infections—2008. http://www.who.int/reproductivehealth/publications/rtis/stisestimates/en/. Published 2014. Accessed November23, 2014.
60. AverageHeight. Average male height by country. http://www.averageheight.co/average-male-height-by-country. Published 2014. Accessed November23, 2014.
61. Johnston WR. Known nuclear explosions:summary. http://www.johnstonsarchive.net/nuclear/nuctestsum.html. Published 2009. Accessed November23, 2014.
62. Dubrova YE, Bersimbaev RI, Djansugurova LB, et al. Nuclear weapons tests and human germline mutation rate. Science. 2002;295:1037.
63. Ortiz I, Cummins M. Global inequality:beyond the bottom billion—a rapid review of income distribution in 141 countries. http://www.unicef.org/socialpolicy/index_58230.html. UNICEF working paper. Published 2011. Accessed October22, 2014.